The global polymerases market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing demand for DNA sequencing and genotyping services, growing number of research projects in the field of biotechnology and pharmaceuticals, and increasing demand for polymerase chain reaction (PCR) kits.
The global polymerases market is segmented on the basis of type into prokaryotic DNA polymerases and eukaryotic DNA polymerase; on the basis of application into academic & research institutes, hospitals & diagnostic centers, pharmaceutical & biotechnology companies; and on the basis of region into North America, Latin America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA). The prokaryotic DNA polymerases segment accounted for a major share in 2017 owing to its wide usage in molecular biology laboratories. The eukaryotic DNA polymerase segment is expected to grow at a higher CAGR during the forecast period due to its use in PCR applications.
Some Of The Growth Factors Of This Market:
- The increasing demand for DNA sequencing is driving the growth of polymerases market.
- The increasing number of research and development activities in the field of polymerases is also driving the growth of this market.
- The growing need for accurate diagnosis and treatment is also driving the growth of polymerases market.
- Increasing awareness about polymerase chain reaction (PCR) among healthcare professionals, researchers, and patients is also fueling the growth of this market.
- Increasing government funding for research in this field will drive the growth of polymerases market.
Industry Growth Insights published a new data on “Polymerases Market”. The research report is titled “Polymerases Market research by Types (Prokaryotic DNA Polymerases, Eukaryotic DNA Polymerase), By Applications (Academic & Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Others), By Players/Companies Thermo Fisher Scientific, Merck, New England Biolabs, Promega, Illumina, Agilent Technologies, F. Hoffmann-la Roche, Takara Bio, QIAGEN N.V., Becton, Dickinson”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Polymerases Market Research Report
By Type
Prokaryotic DNA Polymerases, Eukaryotic DNA Polymerase
By Application
Academic & Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Others
By Companies
Thermo Fisher Scientific, Merck, New England Biolabs, Promega, Illumina, Agilent Technologies, F. Hoffmann-la Roche, Takara Bio, QIAGEN N.V., Becton, Dickinson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Polymerases Market Report Segments:
The global Polymerases market is segmented on the basis of:
Types
Prokaryotic DNA Polymerases, Eukaryotic DNA Polymerase
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic & Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Merck
- New England Biolabs
- Promega
- Illumina
- Agilent Technologies
- F. Hoffmann-la Roche
- Takara Bio
- QIAGEN N.V.
- Becton, Dickinson
Highlights of The Polymerases Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prokaryotic DNA Polymerases
- Eukaryotic DNA Polymerase
- By Application:
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Polymerases Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Polymerases are enzymes that catalyze the polymerization of monomers into polymers.
Some of the major companies in the polymerases market are Thermo Fisher Scientific, Merck, New England Biolabs, Promega, Illumina, Agilent Technologies, F. Hoffmann-la Roche, Takara Bio, QIAGEN N.V., Becton, Dickinson.
The polymerases market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Polymerases Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Polymerases Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Polymerases Market - Supply Chain
4.5. Global Polymerases Market Forecast
4.5.1. Polymerases Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Polymerases Market Size (000 Units) and Y-o-Y Growth
4.5.3. Polymerases Market Absolute $ Opportunity
5. Global Polymerases Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Polymerases Market Size and Volume Forecast by Type
5.3.1. Prokaryotic DNA Polymerases
5.3.2. Eukaryotic DNA Polymerase
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Polymerases Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Polymerases Market Size and Volume Forecast by Application
6.3.1. Academic & Research Institutes
6.3.2. Hospitals & Diagnostic Centers
6.3.3. Pharmaceutical & Biotechnology Companies
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Polymerases Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Polymerases Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Polymerases Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Polymerases Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Polymerases Demand Share Forecast, 2019-2029
9. North America Polymerases Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Polymerases Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Polymerases Market Size and Volume Forecast by Application
9.4.1. Academic & Research Institutes
9.4.2. Hospitals & Diagnostic Centers
9.4.3. Pharmaceutical & Biotechnology Companies
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Polymerases Market Size and Volume Forecast by Type
9.7.1. Prokaryotic DNA Polymerases
9.7.2. Eukaryotic DNA Polymerase
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Polymerases Demand Share Forecast, 2019-2029
10. Latin America Polymerases Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Polymerases Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Polymerases Market Size and Volume Forecast by Application
10.4.1. Academic & Research Institutes
10.4.2. Hospitals & Diagnostic Centers
10.4.3. Pharmaceutical & Biotechnology Companies
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Polymerases Market Size and Volume Forecast by Type
10.7.1. Prokaryotic DNA Polymerases
10.7.2. Eukaryotic DNA Polymerase
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Polymerases Demand Share Forecast, 2019-2029
11. Europe Polymerases Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Polymerases Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Polymerases Market Size and Volume Forecast by Application
11.4.1. Academic & Research Institutes
11.4.2. Hospitals & Diagnostic Centers
11.4.3. Pharmaceutical & Biotechnology Companies
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Polymerases Market Size and Volume Forecast by Type
11.7.1. Prokaryotic DNA Polymerases
11.7.2. Eukaryotic DNA Polymerase
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projctions by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Polymerases Demand Share, 2019-2029
12. Asia Pacific Polymerases Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Polymerases Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Polymerases Market Size and Volume Forecast by Application
12.4.1. Academic & Research Institutes
12.4.2. Hospitals & Diagnostic Centers
12.4.3. Pharmaceutical & Biotechnology Companies
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Polymerases Market Size and Volume Forecast by Type
12.7.1. Prokaryotic DNA Polymerases
12.7.2. Eukaryotic DNA Polymerase
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Polymerases Demand Share, 2019-2029
13. Middle East & Africa Polymerases Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Polymerases Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Polymerases Market Size and Volume Forecast by Application
13.4.1. Academic & Research Institutes
13.4.2. Hospitals & Diagnostic Centers
13.4.3. Pharmaceutical & Biotechnology Companies
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Polymerases Market Size and Volume Forecast by Type
13.7.1. Prokaryotic DNA Polymerases
13.7.2. Eukaryotic DNA Polymerase
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Polymerases Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Polymerases Market: Market Share Analysis
14.2. Polymerases Distributors and Customers
14.3. Polymerases Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. New England Biolabs
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Promega
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Illumina
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Agilent Technologies
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. F. Hoffmann-la Roche
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Takara Bio
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. QIAGEN N.V.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Becton, Dickinson
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
